BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25219)

  • 1. [Beta-blockaders and cardiovascular treatment: facts and theories. Part II. Therapeutic indications: ischemic heart disease and arrhythmia; limitations; conclusions].
    Motolese M
    G Ital Cardiol; 1978; 8(3):333-49. PubMed ID: 25219
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-adrenergic inhibitors and coronary insufficiency].
    Juliard JM; Dahan M; Cohen Solal A; Gourgon R
    Therapie; 1985; 40(6):393-6. PubMed ID: 2868533
    [No Abstract]   [Full Text] [Related]  

  • 3. [The beta-blockers in coronary disease].
    Broustet JP; Sermon F; Rumeau P; Pic A
    Rev Prat; 1984 Apr; 34(19):953-64. PubMed ID: 6144162
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta-blockaders and cardiovascular therapy: facts and theories. Part I. Introduction, characterization; therapeutic indications: arterial hypertension].
    Motolese M
    G Ital Cardiol; 1978; 8(2):218-31. PubMed ID: 25821
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy using beta-receptor blockaders in coronary disease].
    Bolte HD
    Internist (Berl); 1978 Sep; 19(9):520-6. PubMed ID: 29850
    [No Abstract]   [Full Text] [Related]  

  • 6. [Up-dating the treatment with beta-blockaders in cardiology].
    Rubio Sanz R; Asin Cardiel E; Rubio Sanz J
    Rev Clin Esp; 1977 Oct; 147(1):103-12. PubMed ID: 22106
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-adrenergic blockaders in cardiology].
    Muniz M
    Arq Bras Cardiol; 1979 Oct; 33(4):283-92. PubMed ID: 44836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Choice of beta-blocking agents].
    Iisalo E
    Duodecim; 1986; 102(22):1642-50. PubMed ID: 2879719
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta blockade.
    Shah S
    Indian Heart J; 1972 Jun; 24():Suppl 1:143-5. PubMed ID: 4147271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of sudden death in ischemic heart disease].
    Tsolov Ts
    Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic properties and therapeutic use of beta adrenergic receptor blocking drugs].
    Shanks RG
    Medicina (B Aires); 1979; 39 Suppl 1():87-99. PubMed ID: 45034
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug treatment following an infarction].
    Lasserre B; Périat M
    Rev Med Suisse Romande; 1994 Aug; 114(8):677-81. PubMed ID: 7939090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of beta blockaders in arrhythmias and ischemic heart disease].
    Rosselot E
    Rev Med Chil; 1982 Dec; 110(12):1224-32. PubMed ID: 6135249
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy with beta-blocking agents in cardiology].
    Dal Palù C
    Minerva Med; 1970 Nov; 61(95):5450-8. PubMed ID: 4395227
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 18. [Verapamil in ischemic pain and arrhythmia].
    Waris E
    Duodecim; 1972; 88(20):1223-32. PubMed ID: 5076303
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenoceptor blocking drugs.
    Prichard BN
    Practitioner; 1977 Oct; 219(1312):501-8. PubMed ID: 22852
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
    Piva M; Ongari R; Dotti F
    Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.